Maryam Ehteshami

1.0k citations

29 papers · 820 indexed · h-index 17

Impact in

Virology top 2%
- HIV Research and Treatment
Hepatology top 5%
- Hepatitis C virus research

Papers in

Virology 13
- HIV Research and Treatment 13
Hepatology 12
- Hepatitis C virus research 12

Co-authors: Raymond F. Schinazi Matthias Götte Leda Bassit Franck Amblard Tarik Asselah Liesl M. Hagan Egor P. Tchesnokov Zhuo Yang
Journals: Journal of Biological Chemistry (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)Clinical Infectious Diseases (1 paper)
Partner nations: United States Canada Netherlands

In The Last Decade

Maryam Ehteshami

29 papers receiving 806 citations

Peers

Countries citing papers authored by Maryam Ehteshami

Since Specialization

Citations

This map shows the geographic impact of Maryam Ehteshami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Ehteshami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Ehteshami more than expected).

Fields of papers citing papers by Maryam Ehteshami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Ehteshami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Ehteshami. The network helps show where Maryam Ehteshami may publish in the future.

Co-authors

The 25 scholars most cited alongside Maryam Ehteshami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maryam Ehteshami Line = papers co-authored together Maryam Ehteshami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir Antiviral Therapy ·Raymond F. Schinazi, Dharmeshkumar Patel, Maryam Ehteshami	2022	10
2	HIV nucleoside reverse transcriptase inhibitors European Journal of Medicinal Chemistry ·Franck Amblard, Dharmeshkumar Patel, Eleftherios Michailidis, Steven J. Coats, 梅盛华, K.-i. Kaida, Marie-ThérèseDroy-Lefaix, Maryam Ehteshami, Raymond F. Schinazi	2022	31
3	Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma Infectious Agents and Cancer ·Л. Н. Ширін, Dmitry Karavaev, Mehdi Norouzi, Maryam Ehteshami, W. A. Criswell, Bille-Genty, ジェトロ中国北アジアチーム, 옥종선, P. Dauncey, Luz Andrea Lazarte Aguirre, Lotta M. Borger, Sepehr Aghajanian, Hongzhang Li, Jinkai Xu	2021	7
4	Characterization of β- d - N ⁴ -Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus Antimicrobial Agents and Chemotherapy ·Maryam Ehteshami, Sijia Tao, Keivan Zandi, Hui‐Mien Hsiao, Yong Jiang, Sei HPENovosibirsk, Franck Amblard, Olivia Ollinger Russell, Andres Merits, Raymond F. Schinazi	2017	62
5	Metabolism of Nucleosides and Nucleotides Prodrugs Current Pharmaceutical Design ·René Núñez Inza, Maryam Ehteshami, Sei HPENovosibirsk, Franck Amblard, Raymond F. Schinazi	2017	12
6	Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase Antimicrobial Agents and Chemotherapy ·Maryam Ehteshami, Longhu Zhou, María Constanza González-Rodríguez, Jadd R. Shelton, Jong Hyun Cho, Hongwang Zhang, Hao Li, Xiao Lu, Tuğba Öztürk, Richard A. Stanton, Franck Amblard, Tamara R. McBrayer, Steven J. Coats, Raymond F. Schinazi	2017	8
7	2′-Chloro,2′-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture Journal of Medicinal Chemistry ·Shaoman Zhou, 哲彦朴, Peng Liu, Longhu Zhou, Maryam Ehteshami, Leda Bassit, Sijia Tao, Robert A. Domaoal, Artur Evangelista Masip, René Núñez Inza, María Constanza González-Rodríguez, Ahmed Khalil, Olivia Ollinger Russell, Tamara R. McBrayer, Tony Whitaker, M.E. Gallardo-Torres, Franck Amblard, Steven J. Coats, Raymond F. Schinazi	2017	19
8	Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities Clinics in Liver Disease ·Haiying Song, Leda Bassit, Maryam Ehteshami, Raymond F. Schinazi	2016	23
9	Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors Bioorganic & Medicinal Chemistry Letters ·Richard A. Stanton, Xiao Lu, Mervi Detorio, Gabriel Torres, Sei HPENovosibirsk, Maryam Ehteshami, Robert A. Domaoal, James H. Nettles, S. Shahrul Yani, Raymond F. Schinazi	2016	15
10	Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer Journal of Biological Chemistry ·Maryam Ehteshami, Monique Nijhuis, Jean Bernatchez, Ondřej Pešout, Suzanne McCormick, Dorien de Jong, Dirk Jochmans, Matthias Götte	2013	13
11	Chutes and ladders in hepatitis C nucleoside drug development Antiviral Research ·Steven J. Coats, Ethel C. Garnier‐Amblard, Franck Amblard, Maryam Ehteshami, María Constanza González-Rodríguez, Hongwang Zhang, Longhu Zhou, Haiying Song, Xiao Lu, S Nishijima, Jadd R. Shelton, Hao Li, Peng Liu, Chengwei Li, Jong Hyun Cho, Phelipe A. de Souza, Shaoman Zhou, Judy S. Mathew, Raymond F. Schinazi	2013	59
12	Binding Kinetics and Affinities of Heterodimeric versus Homodimeric HIV-1 Reverse Transcriptase on DNA–DNA Substrates at the Single-Molecule Level The Journal of Physical Chemistry B ·Robert Lomicka, 苏金刚, Ondřej Pešout, Maryam Ehteshami, Matthias Götte, Gonzalo Cosa	2013	29
13	Impact of Primer-induced Conformational Dynamics of HIV-1 Reverse Transcriptase on Polymerase Translocation and Inhibition Journal of Biological Chemistry ·Anick Auger, Greg L. Beilhartz, Keyin Wang, Elizabeth Cauchon, Jean‐Pierre Falgueyret, Jay A. Grobler, Maryam Ehteshami, Matthias Götte, Roman A. Melnyk	2011	2
14	HIV-1 Reverse Transcriptase Inhibitors: Beyond Classic Nucleosides and Non-Nucleosides Future Virology ·N R Zaripova, Maryam Ehteshami, Greg L. Beilhartz, Matthias Götte	2011	1
15	Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase The Journal of Infectious Diseases ·Viktor von Wyl, Maryam Ehteshami, Jori Symons, Philippe Bürgisser, Monique Nijhuis, Lisa M. Demeter, Sabine Yerly, Jürg Böni, Thomas Klimkait, Rob Schuurman, Bruno Ledergerber, Matthias Götte, Huldrych F. Günthard, (unknown)	2010	23
16	HIV‐1 Reverse Transcriptase Connection Domain Mutations: Dynamics of Emergence and Implications for Success of Combination Antiretroviral Therapy Clinical Infectious Diseases ·Viktor von Wyl, Maryam Ehteshami, Lisa M. Demeter, Philippe Bürgisser, Monique Nijhuis, Jori Symons, Sabine Yerly, Jürg Böni, Thomas Klimkait, Rob Schuurman, Bruno Ledergerber, Matthias Götte, Huldrych F. Günthard	2010	25
17	Effects of mutations in the connection and RNase H domains of HIV-1 reverse transcriptase on drug susceptibility. PubMed ·Maryam Ehteshami, Matthias Götte	2009	22
18	Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms Journal of Biological Chemistry ·Maryam Ehteshami, Greg L. Beilhartz, N R Zaripova, Egor P. Tchesnokov, Suzanne McCormick, Brian Wynhoven, P. Richard Harrigan, Matthias Götte	2008	69
19	Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors” Journal of Biological Chemistry ·Maryam Ehteshami, N R Zaripova, Egor P. Tchesnokov, Chandravanu Dash, Stuart F.J. Le Grice, Sabine Hallenberger, Dirk Jochmans, Matthias Götte	2008	38
20	Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action Journal of Virology ·Dirk Jochmans, Jérôme Deval, Bart Kesteleyn, Herwig Van Marck, NVMO Special Interest Group on Scientific Education, N. P. Balakrishnan, Pascale Dehertogh, Tania Ivens, Marcia Van Ginderen, 和弘上松, Maryam Ehteshami, Piet Wigerinck, Matthias Götte, Kurt Hertogs	2006	77

About Maryam Ehteshami

Maryam Ehteshami is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Physiology, having authored 29 papers that have together received 820 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (13 papers), Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (7 papers), Biochemical and Molecular Research (6 papers), HIV/AIDS Research and Interventions (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and DNA and Nucleic Acid Chemistry (2 papers). The work is most often cited by research in Virology (333 citations), Hepatology (224 citations), Infectious Diseases (513 citations), Epidemiology (293 citations) and Molecular Biology (259 citations). Maryam Ehteshami has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Raymond F. Schinazi, Matthias Götte, Leda Bassit, Franck Amblard, Tarik Asselah, Liesl M. Hagan, Egor P. Tchesnokov, Zhuo Yang, Steven J. Coats and Sijia Tao. Their work appears in journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact